Ligand validation:4UBC

8DG: 8-OXO-2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE

8DG is a Ligand Of Interest in 4UBC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UBC_8DG_A_401	88%	55%	0.105	0.981	0.74	1.01	-	3	0	0	100%	1
4UAZ_8DG_A_403	90%	46%	0.089	0.971	0.87	1.19	-	5	0	0	100%	0.4
4UAW_8DG_A_401	88%	43%	0.103	0.978	0.88	1.32	-	6	0	0	100%	1
4UBB_8DG_A_401	87%	53%	0.1	0.972	0.86	0.95	-	-	1	0	100%	0.6
3MBY_8DG_A_338	84%	56%	0.097	0.96	0.68	1.02	-	3	1	0	100%	1
4UB5_8DG_A_403	83%	52%	0.099	0.957	0.92	0.95	1	2	0	0	100%	1
7KT3_8DG_A_501	98%	29%	0.058	0.984	1.24	1.57	4	5	0	0	100%	1
7KTJ_8DG_A_506	98%	43%	0.064	0.987	0.86	1.32	-	3	0	0	100%	1
5GG6_8DG_A_401	98%	8%	0.059	0.979	2.02	2.55	6	12	0	0	100%	1
5GG8_8DG_A_401	94%	6%	0.079	0.978	1.97	2.97	6	12	1	0	100%	1
7X9H_8DG_A_202	93%	22%	0.075	0.969	0.97	2.26	2	13	0	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.